REG vs SKYE · P/E 34, $12.93B cap vs $25.0M cap
Regency Centers Corporation (REG) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
REG does not have a complete income-statement cache yet.
SKYE does not have a complete income-statement cache yet.
REG currently screens at market cap $12.93B and trailing P/E 33.5. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the REG and SKYE stock pages for the full models.
Not investment advice.